Insider Terminal | SEC Intelligence

Ticker	Company	Reporting Owner	Date	Value (USD)	Type	Form 4
ALNY S ALNYLAM PHARMACEUTICALS, INC. Fitzgerald Kevin Joseph • Officer • CSO & EVP, Head of Research 10b5-1 Sell 2026-03-05 $213,177x4 View Form 4 →
ALNY	ALNYLAM PHARMACEUTICALS, INC.	Fitzgerald Kevin Joseph Officer • CSO & EVP, Head of Research 10b5-1 Sell	2026-03-05	$213,177x4	S	Form 4
ALNY S ALNYLAM PHARMACEUTICALS, INC. Garg Pushkal • Officer • EVP Chief R&D 10b5-1 Sell 2026-03-05 $778,812x4 View Form 4 →
ALNY	ALNYLAM PHARMACEUTICALS, INC.	Garg Pushkal Officer • EVP Chief R&D 10b5-1 Sell	2026-03-05	$778,812x4	S	Form 4
ALNY S ALNYLAM PHARMACEUTICALS, INC. Fitzgerald Kevin Joseph • Officer • CSO & EVP, Head of Research Sell to Cover 2026-03-04 $204,508x8 View Form 4 →
ALNY	ALNYLAM PHARMACEUTICALS, INC.	Fitzgerald Kevin Joseph Officer • CSO & EVP, Head of Research Sell to Cover	2026-03-04	$204,508x8	S	Form 4
ALNY S ALNYLAM PHARMACEUTICALS, INC. Garg Pushkal • Officer • EVP Chief R&D Sell to Cover 2026-03-04 $745,984x8 View Form 4 →
ALNY	ALNYLAM PHARMACEUTICALS, INC.	Garg Pushkal Officer • EVP Chief R&D Sell to Cover	2026-03-04	$745,984x8	S	Form 4
ALNY S ALNYLAM PHARMACEUTICALS, INC. Greenstreet Yvonne • CEO Sell to Cover 2026-03-04 $947,581x8 View Form 4 →
ALNY	ALNYLAM PHARMACEUTICALS, INC.	Greenstreet Yvonne CEO Sell to Cover	2026-03-04	$947,581x8	S	Form 4
ALNY S ALNYLAM PHARMACEUTICALS, INC. Poulton Jeffrey V. • CFO Sell to Cover 2026-03-04 $797,351x8 View Form 4 →
ALNY	ALNYLAM PHARMACEUTICALS, INC.	Poulton Jeffrey V. CFO Sell to Cover	2026-03-04	$797,351x8	S	Form 4
ALNY S ALNYLAM PHARMACEUTICALS, INC. Tanguler Tolga • Officer • EVP, Chief Commercial Officer Sell to Cover 2026-03-04 $745,984x8 View Form 4 →
ALNY	ALNYLAM PHARMACEUTICALS, INC.	Tanguler Tolga Officer • EVP, Chief Commercial Officer Sell to Cover	2026-03-04	$745,984x8	S	Form 4
ALNY S ALNYLAM PHARMACEUTICALS, INC. Fitzgerald Kevin Joseph • Officer • CSO & EVP, Head of Research 10b5-1 Sell 2026-03-03 $528,189x4 View Form 4 →
ALNY	ALNYLAM PHARMACEUTICALS, INC.	Fitzgerald Kevin Joseph Officer • CSO & EVP, Head of Research 10b5-1 Sell	2026-03-03	$528,189x4	S	Form 4
ALNY S ALNYLAM PHARMACEUTICALS, INC. Garg Pushkal • Officer • EVP Chief R&D 10b5-1 Sell 2026-03-03 $567,546x4 View Form 4 →
ALNY	ALNYLAM PHARMACEUTICALS, INC.	Garg Pushkal Officer • EVP Chief R&D 10b5-1 Sell	2026-03-03	$567,546x4	S	Form 4
ALNY S ALNYLAM PHARMACEUTICALS, INC. Fitzgerald Kevin Joseph • Officer • CSO & EVP, Head of Research Sell to Cover 2026-03-02 $523,584x10 View Form 4 →
ALNY	ALNYLAM PHARMACEUTICALS, INC.	Fitzgerald Kevin Joseph Officer • CSO & EVP, Head of Research Sell to Cover	2026-03-02	$523,584x10	S	Form 4
ALNY S ALNYLAM PHARMACEUTICALS, INC. Garg Pushkal • Officer • EVP Chief R&D Sell to Cover 2026-03-02 $562,585x10 View Form 4 →
ALNY	ALNYLAM PHARMACEUTICALS, INC.	Garg Pushkal Officer • EVP Chief R&D Sell to Cover	2026-03-02	$562,585x10	S	Form 4
ALNY S ALNYLAM PHARMACEUTICALS, INC. Greenstreet Yvonne • CEO Sell to Cover 2026-03-02 $2,227,698Largex10 View Form 4 →
ALNY	ALNYLAM PHARMACEUTICALS, INC.	Greenstreet Yvonne CEO Sell to Cover	2026-03-02	$2,227,698Largex10	S	Form 4
ALNY S ALNYLAM PHARMACEUTICALS, INC. Poulton Jeffrey V. • CFO Sell to Cover 2026-03-02 $722,801x10 View Form 4 →
ALNY	ALNYLAM PHARMACEUTICALS, INC.	Poulton Jeffrey V. CFO Sell to Cover	2026-03-02	$722,801x10	S	Form 4
ALNY S ALNYLAM PHARMACEUTICALS, INC. Tanguler Tolga • Officer • EVP, Chief Commercial Officer Sell to Cover 2026-03-02 $523,584x10 View Form 4 →
ALNY	ALNYLAM PHARMACEUTICALS, INC.	Tanguler Tolga Officer • EVP, Chief Commercial Officer Sell to Cover	2026-03-02	$523,584x10	S	Form 4
ALNY S ALNYLAM PHARMACEUTICALS, INC. Garg Pushkal • Officer • EVP Chief R&D 10b5-1 Sell 2026-02-27 $1,533,100Largex5 View Form 4 →
ALNY	ALNYLAM PHARMACEUTICALS, INC.	Garg Pushkal Officer • EVP Chief R&D 10b5-1 Sell	2026-02-27	$1,533,100Largex5	S	Form 4
ALNY S ALNYLAM PHARMACEUTICALS, INC. Fitzgerald Kevin Joseph • Officer • CSO & EVP, Head of Research 10b5-1 Sell 2026-02-17 $677,532 View Form 4 →
ALNY	ALNYLAM PHARMACEUTICALS, INC.	Fitzgerald Kevin Joseph Officer • CSO & EVP, Head of Research 10b5-1 Sell	2026-02-17	$677,532	S	Form 4
ALNY S ALNYLAM PHARMACEUTICALS, INC. Fitzgerald Kevin Joseph • Officer • CSO & EVP, Head of Research Sell to Cover 2026-02-13 $607,448 View Form 4 →
ALNY	ALNYLAM PHARMACEUTICALS, INC.	Fitzgerald Kevin Joseph Officer • CSO & EVP, Head of Research Sell to Cover	2026-02-13	$607,448	S	Form 4
ALNY S ALNYLAM PHARMACEUTICALS, INC. Garg Pushkal • Officer • EVP Chief R&D Sell to Cover 2026-02-13 $695,201 View Form 4 →
ALNY	ALNYLAM PHARMACEUTICALS, INC.	Garg Pushkal Officer • EVP Chief R&D Sell to Cover	2026-02-13	$695,201	S	Form 4
ALNY S ALNYLAM PHARMACEUTICALS, INC. Greenstreet Yvonne • CEO Sell to Cover 2026-02-13 $2,157,542Large View Form 4 →
ALNY	ALNYLAM PHARMACEUTICALS, INC.	Greenstreet Yvonne CEO Sell to Cover	2026-02-13	$2,157,542Large	S	Form 4
ALNY S ALNYLAM PHARMACEUTICALS, INC. Poulton Jeffrey V. • CFO Sell to Cover 2026-02-13 $695,201 View Form 4 →
ALNY	ALNYLAM PHARMACEUTICALS, INC.	Poulton Jeffrey V. CFO Sell to Cover	2026-02-13	$695,201	S	Form 4
ALNY S ALNYLAM PHARMACEUTICALS, INC. Tanguler Tolga • Officer • EVP, Chief Commercial Officer Sell to Cover 2026-02-13 $607,448 View Form 4 →
ALNY	ALNYLAM PHARMACEUTICALS, INC.	Tanguler Tolga Officer • EVP, Chief Commercial Officer Sell to Cover	2026-02-13	$607,448	S	Form 4